• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.一种用于头颈部癌症肿瘤浸润淋巴细胞评估标准化的算法。
Oral Oncol. 2024 May;152:106750. doi: 10.1016/j.oraloncology.2024.106750. Epub 2024 Mar 27.
2
An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.一种用于三阴性乳腺癌预后的开源、自动化肿瘤浸润淋巴细胞算法。
Clin Cancer Res. 2021 Oct 15;27(20):5557-5565. doi: 10.1158/1078-0432.CCR-21-0325. Epub 2021 Jun 4.
3
PD-L1 expression correlates with tumor-infiltrating lymphocytes and better prognosis in patients with HPV-negative head and neck squamous cell carcinomas.PD-L1 表达与 HPV 阴性头颈部鳞状细胞癌患者的肿瘤浸润淋巴细胞及预后相关。
Cancer Immunol Immunother. 2020 Oct;69(10):2089-2100. doi: 10.1007/s00262-020-02604-w. Epub 2020 May 24.
4
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.一种肿瘤浸润淋巴细胞的影像学生物标志物,用于风险分层 HPV 相关口咽癌患者。
J Natl Cancer Inst. 2022 Apr 11;114(4):609-617. doi: 10.1093/jnci/djab215.
5
Quantitative Assessment of Tumor-Infiltrating Lymphocytes Using Machine Learning Predicts Survival in Muscle-Invasive Bladder Cancer.使用机器学习对肿瘤浸润淋巴细胞进行定量评估可预测肌层浸润性膀胱癌的生存期。
J Clin Med. 2022 Nov 29;11(23):7081. doi: 10.3390/jcm11237081.
6
Tumor Infiltrating Lymphocytes are Prognostic Factors and Can Be Markers of Sensitivity to Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma.肿瘤浸润淋巴细胞是预后因素,并且可以作为头颈部鳞状细胞癌对放化疗敏感性的标志物。
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1271-1278. doi: 10.31557/APJCP.2022.23.4.1271.
7
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma.一种用于黑色素瘤预后分析的开源自动化肿瘤浸润淋巴细胞算法。
Nat Commun. 2019 Nov 29;10(1):5440. doi: 10.1038/s41467-019-13043-2.
8
Assessing the prognostic value of tumor-infiltrating CD57+ cells in advanced stage head and neck cancer using QuPath digital image analysis.使用 QuPath 数字图像分析评估晚期头颈部癌症中肿瘤浸润性 CD57+细胞的预后价值。
Virchows Arch. 2022 Aug;481(2):223-231. doi: 10.1007/s00428-022-03323-6. Epub 2022 Apr 22.
9
Gene expression analysis of TIL rich HPV-driven head and neck tumors reveals a distinct B-cell signature when compared to HPV independent tumors.与HPV非依赖性肿瘤相比,富含肿瘤浸润淋巴细胞(TIL)的HPV驱动的头颈部肿瘤的基因表达分析显示出独特的B细胞特征。
Oncotarget. 2016 Aug 30;7(35):56781-56797. doi: 10.18632/oncotarget.10788.
10
Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.基于数字病理的晚期 HPV 阴性头颈部肿瘤肿瘤浸润 T 淋巴细胞评估
Cancer Immunol Immunother. 2020 Apr;69(4):581-591. doi: 10.1007/s00262-020-02481-3. Epub 2020 Jan 24.

引用本文的文献

1
Digital pathology in tau research: A comparison of QuPath and HALO.tau研究中的数字病理学:QuPath与HALO的比较
J Neuropathol Exp Neurol. 2025 Apr 16. doi: 10.1093/jnen/nlaf026.
2
Intratumoral and peritumoral radiomics of MRIs predicts pathologic complete response to neoadjuvant chemoimmunotherapy in patients with head and neck squamous cell carcinoma.MRI 肿瘤内和肿瘤周围放射组学预测头颈部鳞状细胞癌患者新辅助化疗免疫治疗的病理完全缓解。
J Immunother Cancer. 2024 Nov 5;12(11):e009616. doi: 10.1136/jitc-2024-009616.
3
Personalized Treatment Strategies via Integration of Gene Expression Biomarkers in Molecular Profiling of Laryngeal Cancer.通过整合基因表达生物标志物实现喉癌分子谱分析的个性化治疗策略
J Pers Med. 2024 Oct 10;14(10):1048. doi: 10.3390/jpm14101048.

本文引用的文献

1
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLC.基于机器学习的标准组织学图像中肿瘤浸润淋巴细胞评估与 NSCLC 患者免疫治疗结局的相关性。
JAMA Oncol. 2023 Jan 1;9(1):51-60. doi: 10.1001/jamaoncol.2022.4933.
2
Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms.使用机器学习算法对黑色素瘤中肿瘤浸润淋巴细胞进行客观评估作为预后标志物。
EBioMedicine. 2022 Aug;82:104143. doi: 10.1016/j.ebiom.2022.104143. Epub 2022 Jul 7.
3
A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.肿瘤相关基质浸润淋巴细胞的数字评分可预测头颈部鳞状细胞癌的生存。
J Pathol. 2022 Feb;256(2):174-185. doi: 10.1002/path.5819. Epub 2021 Nov 24.
4
An Open-Source, Automated Tumor-Infiltrating Lymphocyte Algorithm for Prognosis in Triple-Negative Breast Cancer.一种用于三阴性乳腺癌预后的开源、自动化肿瘤浸润淋巴细胞算法。
Clin Cancer Res. 2021 Oct 15;27(20):5557-5565. doi: 10.1158/1078-0432.CCR-21-0325. Epub 2021 Jun 4.
5
Head and neck squamous cell carcinoma.头颈部鳞状细胞癌
Nat Rev Dis Primers. 2020 Nov 26;6(1):92. doi: 10.1038/s41572-020-00224-3.
6
Optimizing Treatment De-Escalation in Head and Neck Cancer: Current and Future Perspectives.优化头颈部癌症的降阶梯治疗:现状与未来展望。
Oncologist. 2021 Jan;26(1):40-48. doi: 10.1634/theoncologist.2020-0303. Epub 2020 Sep 21.
7
The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.肿瘤浸润淋巴细胞(TILs)的存在及其不同亚群之间的比例可作为晚期下咽鳞状细胞癌的预后因素。
BMC Cancer. 2020 Aug 5;20(1):731. doi: 10.1186/s12885-020-07234-0.
8
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma.一种用于黑色素瘤预后分析的开源自动化肿瘤浸润淋巴细胞算法。
Nat Commun. 2019 Nov 29;10(1):5440. doi: 10.1038/s41467-019-13043-2.
9
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study.帕博利珠单抗单药或联合化疗对比西妥昔单抗联合化疗用于治疗复发性或转移性头颈部鳞状细胞癌(KEYNOTE-048):一项随机、开放标签、III 期研究。
Lancet. 2019 Nov 23;394(10212):1915-1928. doi: 10.1016/S0140-6736(19)32591-7. Epub 2019 Nov 1.
10
A Novel Digital Score for Abundance of Tumour Infiltrating Lymphocytes Predicts Disease Free Survival in Oral Squamous Cell Carcinoma.一种新的肿瘤浸润淋巴细胞丰度数字评分可预测口腔鳞状细胞癌无病生存。
Sci Rep. 2019 Sep 16;9(1):13341. doi: 10.1038/s41598-019-49710-z.

一种用于头颈部癌症肿瘤浸润淋巴细胞评估标准化的算法。

An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.

机构信息

Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.

Department of Human Oncology and UW Carbone Cancer Center, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA.

出版信息

Oral Oncol. 2024 May;152:106750. doi: 10.1016/j.oraloncology.2024.106750. Epub 2024 Mar 27.

DOI:10.1016/j.oraloncology.2024.106750
PMID:38547779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11060915/
Abstract

PURPOSE

The prognostic and predictive significance of pathologist-read tumor infiltrating lymphocytes (TILs) in head and neck cancers have been demonstrated through multiple studies over the years. TILs have not been broadly adopted clinically, perhaps due to substantial inter-observer variability. In this study, we developed a machine-based algorithm for TIL evaluation in head and neck cancers and validated its prognostic value in independent cohorts.

EXPERIMENTAL DESIGN

A network classifier called NN3-17 was trained to identify and calculate tumor cells, lymphocytes, fibroblasts and "other" cells on hematoxylin-eosin stained sections using the QuPath software. These measurements were used to construct three predefined TIL variables. A retrospective collection of 154 head and neck squamous cell cancer cases was used as the discovery set to identify optimal association of TIL variables and survival. Two independent cohorts of 234 cases were used for validation.

RESULTS

We found that electronic TIL variables were associated with favorable prognosis in both the HPV-positive and -negative cases. After adjusting for clinicopathologic factors, Cox regression analysis demonstrated that electronic total TILs% (p = 0.025) in the HPV-positive and electronic stromal TILs% (p < 0.001) in the HPV-negative population were independent markers of disease specific outcomes (disease free survival).

CONCLUSIONS

Neural network TIL variables demonstrated independent prognostic value in validation cohorts of HPV-positive and HPV-negative head and neck cancers. These objective variables can be calculated by an open-source software and could be considered for testing in a prospective setting to assess potential clinical implications.

摘要

目的

多年来,多项研究已经证明了病理学家解读的肿瘤浸润淋巴细胞(TILs)对头颈部癌症的预后和预测意义。TILs 尚未广泛应用于临床,这可能是由于观察者间存在很大的差异。在这项研究中,我们开发了一种基于机器的头颈部癌症 TIL 评估算法,并在独立队列中验证了其预后价值。

实验设计

一种名为 NN3-17 的网络分类器被训练用于识别和计算苏木精-伊红染色切片上的肿瘤细胞、淋巴细胞、成纤维细胞和“其他”细胞,并使用 QuPath 软件进行计算。这些测量值用于构建三个预先定义的 TIL 变量。我们回顾性地收集了 154 例头颈部鳞状细胞癌病例作为发现集,以确定 TIL 变量与生存的最佳关联。另外两个独立的 234 例病例队列用于验证。

结果

我们发现电子 TIL 变量与 HPV 阳性和阴性病例的预后良好相关。在调整了临床病理因素后,Cox 回归分析表明,HPV 阳性病例中电子总 TILs%(p=0.025)和 HPV 阴性病例中电子基质 TILs%(p<0.001)是疾病特异性结局(无病生存)的独立标志物。

结论

神经网络 TIL 变量在 HPV 阳性和 HPV 阴性头颈部癌症的验证队列中显示出独立的预后价值。这些客观变量可以通过开源软件计算,并可以考虑在前瞻性研究中进行测试,以评估其潜在的临床意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/dea39ce6a7c1/nihms-1982433-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/18e5a4c95a0f/nihms-1982433-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/0313c2e615a5/nihms-1982433-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/6dcbd1ffa796/nihms-1982433-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/dea39ce6a7c1/nihms-1982433-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/18e5a4c95a0f/nihms-1982433-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/0313c2e615a5/nihms-1982433-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/6dcbd1ffa796/nihms-1982433-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b11/11060915/dea39ce6a7c1/nihms-1982433-f0004.jpg